AORT (AORT) investor plans Rule 144 sale of 4,572 shares on NYSE

Rhea-AI Filing Summary

An AORT shareholder filed a Rule 144 notice to sell up to 4,572 shares of common stock through Fidelity Brokerage Services on the NYSE around 12/08/2025. The filing lists an aggregate market value of $203,081.38 for this planned sale, compared with 47,374,939 common shares outstanding for the issuer. The seller acquired these 4,572 shares as restricted stock vesting from the issuer on 12/05/2025, treated as compensation.

Over the prior three months, the same seller reported additional open-market sales of the issuer’s common stock: 1,789 shares on 11/10/2025 for $79,823.21, 3,482 shares on 11/13/2025 for $159,678.60, and 6,000 shares on 11/17/2025 for $274,382.11. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4572	203081.38	47374939	12/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/05/2025	Restricted Stock Vesting	Issuer			4572	12/05/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Amy D. Horton 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	11/10/2025	1789	79823.21
Amy D. Horton 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	11/13/2025	3482	159678.60
Amy D. Horton 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	11/17/2025	6000	274382.11

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the AORT Rule 144 filing disclose about planned share sales?

The filing shows an AORT shareholder intends to sell 4,572 shares of common stock on the NYSE through Fidelity Brokerage Services LLC around 12/08/2025, with an aggregate market value of $203,081.38.

How many AORT shares are outstanding according to this Rule 144 notice?

The notice states that 47,374,939 shares of common stock were outstanding for the issuer, providing context for the size of the planned 4,572-share sale.

How did the seller acquire the 4,572 AORT shares to be sold under Rule 144?

The filing reports that the 4,572 shares to be sold were acquired on 12/05/2025 through restricted stock vesting from the issuer, classified as compensation.

What AORT stock sales has the shareholder made in the past three months?

The shareholder reported selling 1,789 shares on 11/10/2025 for $79,823.21, 3,482 shares on 11/13/2025 for $159,678.60, and 6,000 shares on 11/17/2025 for $274,382.11.

What representation does the AORT shareholder make about inside information?

By signing the notice, the shareholder represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

What brokerage firm is handling the planned AORT Rule 144 sale?

The planned sale of 4,572 AORT common shares is listed as being executed through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, on the NYSE.